Ilsung Is Co., Ltd. (KRX:003120)

South Korea flag South Korea · Delayed Price · Currency is KRW
26,400
-100 (-0.38%)
At close: Jul 24, 2025, 3:30 PM KST
-0.38%
Market Cap183.28B
Revenue (ttm)69.65B
Net Income (ttm)15.30B
Shares Out6.97M
EPS (ttm)2,244.75
PE Ratio11.72
Forward PEn/a
Dividend1,500.00 (5.70%)
Ex-Dividend DateDec 27, 2024
Volume20,636
Average Volume81,187
Open27,400
Previous Close26,500
Day's Range26,350 - 27,400
52-Week Range14,500 - 31,450
Beta-0.25
RSI56.94
Earnings DateAug 14, 2025

About Ilsung Is

Ilsung Is Co., Ltd. operates as a pharmaceutical company in South Korea. Its products include antibiotics, analgesics, muscle relaxants, antipyretic-analgesics, antihistamine, neuropsychiatric, neuromuscular blocker/ central muscle relaxants, anti-coagulants, probiotics, vaccine, medical equipment, circulatory system drugs, contrast agents, muscle relaxants, diabetes treatments, osteopathic, digestive system medicines, anti-virals, anti-emetics, respiratory treatments, adrenal cortical steroids, anesthetics, antipyretics, and cardiovascular sys... [Read more]

Sector Healthcare
Founded 1954
Country South Korea
Stock Exchange Korea Stock Exchange
Ticker Symbol 003120
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.